Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 25 tags : Pharmaceuticals save search
Supernus Pharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 8, 2022
Published: 2022-10-25 (Crawled : 21:00) - globenewswire.com
SUPN | $30.26 1.04% 1.02% 200K
|
Health Technology
|
| O: 0.73%
H: 1.2%
C: 0.14%
pharmaceuticals conference financial results
Corvus Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant as Potential First Line Treatment for Patients with Renal Cell Cancer
Published: 2022-10-25 (Crawled : 20:00) - globenewswire.com
CRVS | $1.51 -1.31% 3.16% 100
|
Health Technology
|
| O: 3.56%
H: 2.67%
C: -3.51%
treatment pharmaceuticals renal trial potential cancer phase 2b
Rhythm Pharmaceuticals to Present Full Data from Phase 2 Clinical Trial Evaluating Setmelanotide in Hypothalamic Obesity at ObesityWeek® 2022
Published: 2022-10-25 (Crawled : 15:00) - globenewswire.com
RYTM 4 | $39.71 -0.73% -0.73% 400K
|
Health Technology
|
| O: 1.03%
H: 7.31%
C: 3.31%
obesityweek obesity pharmaceuticals trial setmelanotide phase 2
Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive Ichthyosis
Published: 2022-10-25 (Crawled : 13:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 2.67%
H: 1.3%
C: -3.51%
tmb-001 pharmaceuticals designation positive
Marinus Pharmaceuticals to Provide Business Update and Report Third Quarter 2022 Financial Results on November 8, 2022
Published: 2022-10-25 (Crawled : 12:20) - biospace.com/
MRNS | $1.44 0.0% 1.3M
|
Health Technology
|
| O: -0.21%
H: 5.12%
C: 3.41%
pharmaceuticals report financial update results
Paratek Pharmaceuticals to Report Third-Quarter 2022 Financial Results on Nov. 3
Published: 2022-10-25 (Crawled : 12:00) - globenewswire.com
PRTK | $2.23 0.0% 4.8M
|
Health Technology
|
| O: 0.0%
H: 8.43%
C: 6.93%
pharmaceuticals report financial results
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022
Published: 2022-10-25 (Crawled : 12:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 220
|
Health Technology
|
| O: 0.7%
H: 4.02%
C: 2.85%
pharmaceuticals report financial results
Milestone Pharmaceuticals Announces Late-Breaking Presentation of Data from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray
Published: 2022-10-25 (Crawled : 12:00) - biospace.com/
MIST | $1.66 -2.35% -1.8% 49K
|
Health Technology
|
| O: 0.79%
H: 14.87%
C: 7.44%
etripamil pharmaceuticals spray rapid trial presentation milestone
Tonix Pharmaceuticals Announces Pricing of $15 Million Private Placement of Convertible Redeemable Preferred Stock
Published: 2022-10-25 (Crawled : 11:00) - globenewswire.com
TNXP | $0.16 2.04% 1.2% 940K
|
Health Technology
|
| O: 1.36%
H: 4.0%
C: -0.2%
pharmaceuticals
Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC
Published: 2022-10-25 (Crawled : 11:00) - globenewswire.com
FUSN | $21.4 -0.09% -0.09% 320
|
Health Technology
|
| O: -0.42%
H: 3.77%
C: -4.26%
DFFN 4 | $6.6 11.68% -34.32% 350K
|
Health Technology
|
| O: 2.15%
H: 5.46%
C: 3.99%
pharmaceuticals review
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.